Skip to main content Skip to section navigation Skip to footer
Global leader in temperature-controlled supply chain solutions for the life sciences
Cryport, Inc. Corporate Home
  • About Us
    • Company History
    • Management Team
  • Cryoport’s Business Units
  • ESG Policy
  • Investor Relations
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • Careers

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • Information Request
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 07, 2025 4:05 pm EDT
Cryoport Reports First Quarter 2025 Financial Results
Apr 24, 2025 8:30 am EDT
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
Mar 31, 2025 9:06 am EDT
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
Mar 31, 2025 8:09 am EDT
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
Mar 12, 2025 8:30 am EDT
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
Mar 04, 2025 4:10 pm EST
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 18, 2025 8:30 am EST
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Jan 21, 2025 8:30 am EST
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
Jan 14, 2025 8:30 am EST
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Jan 06, 2025 8:30 am EST
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 39
  • Next Pagearrow_forward
rss_feed News RSS
  • Accessibility statement
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
  • Cryoport Systems
  • MVE Biological Solutions
  • CRYOPDP
  • CRYOGENE
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
Cryoport, Inc. logo
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Careers
  • Newsletter
  • Manage Cookie Preferences

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

Receive Financial Updates
  • youtube
  • x
  • linkedin

Investor Contacts

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Cryoport, Inc. logo

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

©2025 Cryoport Inc. All Rights Reserved.

  • youtube
  • x
  • linkedin